to

Adding the missing sugars to coronavirus protein structures

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system




to

Vir taps Samsung to produce coronavirus candidate




to

Blackstone invests in Alnylam's RNAi therapies




to

MOMA Therapeutics launches with $86 million series A to drug molecular machines




to

How one ACS division took its Philadelphia technical program virtual

Members of the Division of Colloid and Surface Chemistry presented 155 virtual talks over 3 days




to

DuPont teams up with FedEx and US government to speed PPE production




to

How susceptible is your cat or dog to the novel coronavirus?

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds




to

India aims to be a global hub for drug production




to

Yeasty treats to get you through the pandemic




to

Environmental toxicologist wants to understand how microplastics affect human health

Stephanie Wright of King's College London discusses what's known about microplastics and how much more there is to learn




to

NIH unveils consortium to tackle COVID-19 research

Multiple government agencies and pharma companies join the effort to develop therapeutics and vaccines




to

US chemical output to drop this year

Novel coronavirus shutdown is choking demand for chemicals as well as investment, key trade group says




to

Adding the missing sugars to coronavirus protein structures

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system




to

NIH unveils consortium to tackle COVID-19 research

Multiple government agencies and pharma companies join the effort to develop therapeutics and vaccines




to

Groups urge US EPA to strengthen PFAS rule

Latest proposal to restrict imports containing certain long-chain PFAS is narrower in scope than original




to

Heavy water causes yeast to build cell wall in overdrive

Researchers pinpoint how cells respond to an unusual stressor




to

Clinical trials planned to put hydroxychloroquine to the test for COVID-19

The antimalaria drug will be tested for treating or preventing the disease in thousands of people worldwide




to

Kebotix raises funds for R&D automation




to

Michelin partners with Enviro to recycle tires with pyrolysis




to

Nitrome raises $38 million to drug Parkinson's enzyme




to

Ineos to squeeze oil from waste plastic




to

Lending a machine to combat COVID-19




to

Electrocatalytic method converts CO₂ to ethylene and ethanol

Fluorine-doped copper catalyst boosts efficiency and selectivity




to

<i>Science</i> editor in chief Holden Thorp on the role of science during the COVID-19 pandemic

The chemist and former university administrator uses editorials to speak up for science during an ‘extraordinary' time




to

Chemistry educators try ‘ungrading' techniques to help students learn

The approach aims to give STEM students more dialogue in their education and free them from the constant pressure of assessment




to

Rome Therapeutics launches to probe junk DNA for cancer drug discovery

Biotech veteran Rosana Kapeller co-founded the start-up, which raised $50 million to develop small-molecule drugs




to

Incinerators may spread, not break down PFAS

Preliminary data show soil and water near New York facility are contaminated




to

During the coronavirus pandemic, hospitals have taken unprecedented steps to disinfect N95 face masks

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable




to

Dry cleaning solvent poses health risks to workers and consumers

US EPA draft evaluation finds neurological effects associated with exposure to perchloroethylene




to

As they scramble to shore up supplies, small firms brace for a recession

Early signs of a downturn in demand herald a season of unprecedented uncertainty




to

Rome Therapeutics launches to probe junk DNA for cancer drug discovery

Biotech veteran Rosana Kapeller cofounded the start-up, which raised $50 million to develop small-molecule drugs




to

A chemist's guide to disinfectants

Has your local store run out of sanitizing wipes? This cheat sheet can help you find and understand alternatives




to

Moderna picks Lonza to make 1 billion doses of its coronavirus vaccine

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine




to

J&J picks Emergent to make COVID-19 vaccine




to

Vertex signs viral vector R&D pact with Affinia




to

Incinerators may spread, not break down, PFAS

Preliminary data show soil and water near New York facility are contaminated




to

LG Chem to invest $53.5 million in carbon nanotubes for batteries




to

The mystery of the letter to the editor




to

Turning worry into work




to

Xiaogang Liu is using fluorescence to tackle the problem of illicit cooking oil

The Singapore-based physical chemist is building a database of fluorescence fingerprints to help nab adulterated food products




to

During the coronavirus pandemic, hospitals have taken unprecedented steps to disinfect N95 face masks

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable




to

Chemists elected to National Academy of Sciences

Prestigious recognition honors distinguished achievements in research




to

Moderna picks Lonza to make 1 billion doses of its coronavirus vaccine

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine




to

Ventus Therapeutics launches to drug inflammasomes, cGAS, and more

The Versant-founded start-up raised $60 million to develop small molecules that target innate immune system proteins




to

Evonik to boost drug actives capacity in Germany

Project joins a steady flow of investment boosted by heightened supply chain concerns




to

Vapor-phase treatment customizes MOFs

Method exchanges framework linkers with others that cannot be incorporated via traditional synthesis techniques




to

ACC seeks lower tariffs to aid COVID-19 fight




to

Alexion to acquire biotech firm Portola




to

Praxis Precision Medicines launches with $100 million to develop neuroscience drugs




to

Gene therapy expert leads project to develop AAV-based COVID-19 vaccine